[LGND] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 145.14%
YoY- -97.06%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 32,868 66,088 64,835 41,848 24,808 45,663 33,375 -0.25%
PBT -15,344 857 15,259 -11,612 -19,871 79,226 12,071 -
Tax -2,552 453 1,536 -4,911 -4,620 11,864 3,645 -
NP -12,792 404 13,723 -6,701 -15,251 67,362 8,426 -
Tax Rate - -52.86% -10.07% - - -14.97% -30.20% -
Total Cost 45,660 65,684 51,112 48,549 40,059 -21,699 24,949 10.59%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -38.92 0.61 21.17 -16.01 -61.48 147.52 25.25 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.74 0.02 0.82 -0.42 -0.81 3.19 0.40 -
EPS Diluted -0.74 0.02 0.80 -0.42 -0.81 2.80 0.36 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.